Determinants of patient-reported outcome trajectories and symptomatic recovery in Improving Access to Psychological Therapies (IAPT) services by Stochl, Jan et al.
                                                                    
University of Dundee
Determinants of patient-reported outcome trajectories and symptomatic recovery in
Improving Access to Psychological Therapies (IAPT) services









Publisher's PDF, also known as Version of record
Link to publication in Discovery Research Portal
Citation for published version (APA):
Stochl, J., Soneson, E., Stuart, F., Fritz, J., Walsh, A. E. L., Croudace, T., Hodgekins, J., Patel, U., Russo, D. A.,
Knight, C., Jones, P. B., & Perez, J. (2021). Determinants of patient-reported outcome trajectories and
symptomatic recovery in Improving Access to Psychological Therapies (IAPT) services. Psychological Medicine.
https://doi.org/10.1017/S0033291720005395
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.






Cite this article: Stochl J et al (2021).
Determinants of patient-reported outcome
trajectories and symptomatic recovery in
Improving Access to Psychological Therapies
(IAPT) services. Psychological Medicine 1–10.
https://doi.org/10.1017/S0033291720005395
Received: 11 May 2020
Revised: 18 December 2020




Improving Access to Psychological Therapies
Author for correspondence:
Jan Stochl, E-mail: js883@cam.ac.uk
© The Author(s), 2021. Published by
Cambridge University Press. This is an Open
Access article, distributed under the terms of
the Creative Commons Attribution licence
(http://creativecommons.org/licenses/by/4.0),
which permits unrestricted re- use,
distribution and reproduction, provided the
original article is properly cited.
Determinants of patient-reported outcome
trajectories and symptomatic recovery in
Improving Access to Psychological Therapies
(IAPT) services
Jan Stochl1,2,3,* , Emma Soneson1,*, Freya Stuart1, Jessica Fritz1,
Annabel E. L. Walsh4, Tim Croudace5, Joanne Hodgekins6, Ushma Patel1,7,
Debra A. Russo1, Clare Knight1, Peter B. Jones1,2,7,† and Jesus Perez1,2,7,†
1Department of Psychiatry, University of Cambridge, Cambridge, UK; 2National Institute for Health Research
Applied Research Collaboration (ARC) East of England (EoE), Cambridge, UK; 3Department of Kinanthropology,
Charles University, Prague, Czechia; 4Institution of Psychiatry, Psychology and Neuroscience, King’s College
London, London, UK; 5School of Health Sciences, University of Dundee, Dundee, UK; 6Norwich Medical
School, University of East Anglia, Norwich, UK and 7Cambridgeshire & Peterborough NHS Foundation Trust,
Cambridge, UK
Abstract
Background. Despite evidence for the general effectiveness of psychological therapies, there
exists substantial heterogeneity in patient outcomes. We aimed to identify factors associated
with baseline severity of depression and anxiety symptoms, rate of symptomatic change over
the course of therapy, and symptomatic recovery in a primary mental health care setting.
Methods. Using data from a service evaluation involving 35 527 patients in England’s psycho-
logical and wellbeing [Improving Access to Psychological Therapies (IAPT)] services, we
applied latent growth models to explore which routinely-collected sociodemographic, clinical,
and therapeutic variables were associated with baseline symptom severity and rate of symp-
tomatic change. We used a multilevel logit model to determine variables associated with
symptomatic recovery.
Results. Being female, younger, more functionally impaired, and more socioeconomically
disadvantaged was associated with higher baseline severity of both depression and anxiety
symptoms. Being older, less functionally impaired, and having more severe baseline symptom-
atology was associated with more rapid improvement of both depression and anxiety symp-
toms (male gender and greater socioeconomic disadvantage were further associated with
rate of change for depression only). Therapy intensity and appointment frequency seemed
to have no correlation with rate of symptomatic improvement. Patients with lower baseline
symptom severity, less functional impairment, and older age had a greater likelihood of
achieving symptomatic recovery (as defined by IAPT criteria).
Conclusions. We must continue to investigate how best to tailor psychotherapeutic interven-
tions to fit patients’ needs. Patients who begin therapy with more severe depression and/or
anxiety symptoms and poorer functioning merit special attention, as these characteristics
may negatively impact recovery.
Introduction
Evidence abounds for the effectiveness of psychological therapies in treating a wide range of
mental health problems (Barth et al., 2013; Cristea et al., 2017; Cuijpers, Cristea, Karyotaki,
Reijnders, & Huibers, 2016; Cuijpers et al., 2014a; 2014b; Lambert, 2013). However, it is widely
acknowledged that treatment outcomes vary greatly between individuals with a significant pro-
portion not responding at all (Van, Dekker, Peen, Van Aalst, & Schoevers, 2008a; Van et al.,
2008b). The ability to explain why individuals respond differently to therapy provides import-
ant supplementary information to advance our understanding of ‘what works for whom’
(Green et al., 2015; Van et al., 2008a). Characterising the basis of heterogeneity in baseline
symptom severity, rates of symptomatic change during therapy, and treatment outcomes
enables us to identify variables related to treatment success and thus may constitute a step
towards more personalised care. Furthermore, provision of appropriate, tailored treatment
enables efficient allocation of limited mental health resources.
Much effort has gone into understanding the reasons for variation in therapy response. At
the patient level alone, more than 200 factors have been proposed to potentially influence ther-
apy outcomes (Norcross & Wampold, 2011). These variables include sociodemographic char-
acteristics [e.g. age (Amati, Banks, Greenfield, & Green, 2018; Marttunen, Välikoski, Lindfors,
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Laaksonen, & Knekt, 2008; Robinson, Kellett, & Delgadillo, 2020;
Wolitzky-Taylor, Arch, Rosenfield, & Craske, 2012), gender
(Amati et al., 2018; Cuijpers et al., 2014a, 2014b;
Wolitzky-Taylor et al., 2012), socioeconomic status (Amati
et al., 2018; Green et al., 2015; Marttunen et al., 2008), and ethni-
city (Amati et al., 2018; Green et al., 2015; Robinson et al., 2020;
Saxon, Firth, & Barkham, 2017; Wolitzky-Taylor et al., 2012)],
mental health-related clinical variables [e.g. pre-treatment dis-
order severity (Amati et al., 2018; Green et al., 2015; Gyani,
Shafran, Layard, & Clark, 2013a; 2013b; Marttunen et al., 2008;
Robinson et al., 2020; Saxon et al., 2017; Van et al., 2008a;
Wolitzky-Taylor et al., 2012), comorbidities (Amati et al., 2018;
Goddard, Wingrove, & Moran, 2015; Marttunen et al., 2008;
Wolitzky-Taylor et al., 2012), and psychiatric history
(Marttunen et al., 2008)], social functioning and support
(Amati et al., 2018; Lindfors, Ojanen, Jääskeläinen, & Knekt,
2014; Wang, Mann, Lloyd-Evans, Ma, & Johnson, 2018), and per-
sonality traits (Bucher, Suzuki, & Samuel, 2019; Laaksonen,
Knekt, & Lindfors, 2013a; Laaksonen, Knekt, Sares-Jäske, &
Lindfors, 2013b). Outcomes further vary by treatment variables
[e.g. therapy modality (Amati et al., 2018; Gyani et al., 2013a,
2013b; Marttunen et al., 2008), number of sessions attended
(Amati et al., 2018; Gyani et al., 2013a, 2013b; Norcross &
Wampold, 2011) and missed (Amati et al., 2018; Green et al.,
2015; Van et al., 2008a), time waited to start treatment (Clark
et al., 2018), therapy setting (Amati et al., 2018), frequency of ses-
sions (Tiemens et al., 2019), therapeutic alliance (Del Re,
Flückiger, Horvath, Symonds, & Wampold, 2012; Horvath, Del
Re, Flückiger, & Symonds, 2011), treatment engagement
(Dixon, Holoshitz, & Nossel, 2016), and patient expectations of
therapy outcome (Porter & Chambless, 2015)] as well as on ther-
apist characteristics and experience (Amati et al., 2018; Gyani
et al., 2013a, 2013b; Nissen-Lie, Monsen, Ulleberg, &
Rønnestad, 2013). Although some of these factors influence treat-
ment outcome in a consistent direction [good therapeutic alli-
ance, for example, consistently leads to more positive outcomes
(Del Re et al., 2012; Horvath et al., 2011)], several show inconclu-
sive evidence regarding direction of effect (Amati et al., 2018).
Individuals may further vary in their progression through
therapy, leading to heterogeneity in treatment response trajector-
ies (Green et al., 2015). These trajectories are informative for
understanding progress as well as predicting outcomes (Comninos
& Grenyer, 2007; Lutz, Stulz, & Kock, 2009; Lutz et al., 2014;
Stulz, Lutz, Leach, Lucock, & Barkham, 2007). Research has
aimed to characterise differences in treatment response trajectories,
largely through class-based approaches that classify sub-groups of
patients with homogeneous treatment response trajectories and
determine predictors of group membership. These studies have
identified a varying number of such sub-groups for a wide range
of disorders, including depression (Cuijpers, Van Lier, Van
Straten, & Donker, 2005; Gunn et al., 2013; Lutz et al., 2009;
Sunderland, Wong, Hilvert-Bruce, & Andrews, 2012), anxiety
(Sunderland et al., 2012), panic disorder (Lutz et al., 2014), post-
traumatic stress disorder (PTSD) (Elliott, Biddle, Hawthorne,
Forbes, & Creamer, 2005; Stein, Dickstein, Schuster, Litz, &
Resick, 2012), and first-episode psychosis (Hodgekins et al., 2015).
Previous studies of both therapy outcomes and treatment
response trajectories in psychological therapy have some limita-
tions. First, with few exceptions (e.g. Ali et al., 2014; Flückiger,
Grosse Holtforth, Znoj, Caspar, & Wampold, 2013; Green,
Barkham, Kellett, & Saxon, 2014; Lutz, Martinovich, Lyons,
Leon, & Stiles, 2007; Saxon et al., 2017), they have not accounted
for the structure of longitudinal data in which patients are nested
under individual therapists. Failure to take into account this hier-
archical data structure can result in biased statistical inferences
(Stochl et al., 2014). Second, many of the previous studies have
relied upon specialised, non-routine variables (e.g. measures of
therapeutic alliance). Although these provide valuable insights,
there is a practical need for easily identifiable, routinely-collected
variables, including patients’ sociodemographic characteristics
and clinical features (Van et al., 2008a).
These limitations highlight a need for robust studies that use
appropriately complex multilevel models to cope with hierarchical
and longitudinal dependencies, as well as convenient [i.e. readily
available in Improving Access to Psychological Therapies’ (IAPT)
routinely-collected variables] and practical (i.e. relevant to out-
comes of interest) variables to explain heterogeneity in treatment
response trajectories and symptomatic recovery. In this explora-
tory analysis, we aimed to identify variables that are associated
with (1) baseline symptom severity, (2) rate of symptomatic
change, and (3) symptomatic recovery of patients receiving psy-




The IAPT programme in England began in 2008 with a direct
objective to increase public access to National Institute for
Health and Care Excellence (NICE)-approved psychological ther-
apies for depression and anxiety. IAPT currently assesses over
1 300 000 people annually and delivers therapy to approximately
550 000. The programme offers low- (step 2) and high-intensity
(step 3) treatments. Low-intensity approaches include guided self-
help, psychoeducation, computerised cognitive–behavioural therapy
(CBT), behavioural activation, and structured group activity pro-
grammes (Clark, 2018). In high-intensity services, face-to-face CBT
is the predominant approach, although there is a wider range of
recommended treatments (e.g. eye movement desensitisation and
reprocessing, interpersonal psychotherapy, counselling for depres-
sion, compassion-focused therapy, and integrative counselling). On
average, patients receive seven sessions over a period of 3–4 months.
At each session, therapists assess depression and anxiety symp-
toms using the 9-item Patient Health Questionnaire (PHQ-9)
(Kroenke, Spitzer, & Williams, 2001) and the 7-item Generalised
Anxiety Disorder assessment (GAD-7) (Spitzer, Kroenke, Williams,
& Lowe, 2006), respectively. IAPT services adopted these scales
nationally because of their good psychometric properties
(Cameron, Crawford, Lawton, & Reid, 2008; Titov et al., 2011)
and brevity, and they use them tomonitor improvement and recov-
ery rates. Total scores are computed as sum scores of items
(response categories: 0 = Not at all; 1 = Several days, 2 =More
than half the days; 3 = Nearly every day). PHQ-9 scores range
from 0 (no depression) to 27 (severe depression), while GAD-7
scores range between 0 (no anxiety) and 21 (severe anxiety). In
IAPT, individuals are described at ‘caseness’, if they score above
the clinical cut-off for depression (PHQ-9 ⩾ 10) (Manea, Gilbody,
& McMillan, 2012) and/or anxiety (GAD-7⩾ 8).
Participants
The primary sample consisted of 35 527 individuals across
Cambridgeshire and Peterborough NHS Foundation Trust and
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Sussex Partnership NHS Foundation Trust who accessed IAPT
services between February 2018 and December 2018. We
excluded 6717 individuals deemed not suitable for the service
after initial assessment and those with no longitudinal data (i.e.
who only attended one appointment). The sample analysed for
determinants of baseline symptom severity and rate of symptom-
atic change consisted of 28 810 individuals (Table 1).
To assess which variables were associated with symptomatic
recovery, we analysed therapy outcomes for a subsample of 8114
individuals comprising those patients who (a) had non-missing
values for both PHQ-9 and GAD-7 scores at first and last assess-
ment (n = 27 835); (b) were considered at ‘caseness’ at initial assess-
ment (i.e. PHQ-9 and/or GAD-7 score was above clinical cut-off, n
= 20 959); (c) had completed treatment (in any number of sessions,
n = 10 3081†); and (d) had non-missing values on all variables
hypothesised to be associated with outcomes (n = 8114). Over
67% (5438) achieved symptomatic recovery.
Outcomes
Our outcomes of interest were baseline symptom severity, rate of
symptomatic change, and symptomatic recovery. We inferred
each patient’s baseline symptom severity and rate of symptomatic
change from their growth curve (hereafter denoted as treatment
response trajectory), which is estimated using total scores on the
corresponding scale across therapy appointments. Symptomatic
recovery in IAPT is achieved when a patient who is at ‘caseness’
at pre-treatment has dropped below the clinical cut-off for both
depression and anxiety post-treatment (i.e. PHQ-9 < 10 and
GAD-7 < 8) (National Collaborating Centre for Mental Health,
2018).
Variables tested for association with outcomes
The set of variables tested for associations with our outcomes of
interest included three sociodemographic variables (gender, age,
and socioeconomic status), two clinical variables (baseline symp-
tom severity and baseline level of functioning), and three thera-
peutic variables [therapy intensity (low- (step 2) or
high-intensity (step 3)), therapy frequency (median number of
days between sessions), and the number of patients treated by
an individual therapist (caseload)]. All of these variables were dir-
ectly obtained or derived from data routinely collected in IAPT
services (see online Supplementary Table S1 for a detailed variable
list).
Baseline level of functioning was measured using the 5-item
self-report Work and Social Adjustment Scale (WSAS) (Mundt,
Marks, Shear, & Greist, 2002), which measures personal, occupa-
tional, and social functional impairment. Each item on the WSAS
is scored from 0 (no impairment) to 8 (severe impairment), hence
total scores range from 0 to 40, with higher total scores indicating
more severe impairment.
Socioeconomic status was estimated using the index of multiple
deprivation (IMD). IMD deciles are publicly available data for
postcodes across the UK. Anonymised data provided by IAPT,
however, included only the outward area postcode. The IMD
for each individual was therefore estimated as a median IMD
decile for the corresponding outward area, with lower values
representing higher deprivation.
Statistical analysis
We used growth models to estimate patients’ treatment response
trajectories of depression and anxiety symptoms. This modelling
approach fits, for each patient, a non-linear trend for the total scores
of PHQ-9 or GAD-7 over the course of therapy. We inferred values
for baseline symptom severity and rate of symptomatic change from
the intercept and slope of patients’ treatment response trajectories,
respectively. In all analyses we used full information maximum like-
lihood estimator to account for data missingness.
The IAPT treatment model is based on 12–20 sessions as set
out in the NICE guidelines. Very few individuals attended more
than 20 appointments and thus we only used the first 20 appoint-
ments for each patient. We first estimated the basic nonlinear
growth model (with intercept, slope, and quadratic term as latent
variables) anchored at every attended appointment (see online
Supplementary Fig. S1).
At this stage, we investigated whether the individual treatment tra-
jectories clustered into homogeneous classes using a growth mixture
model. If few interpretable classes were found, then the variables asso-
ciated with baseline symptom severity and rate of symptomatic change
could be considered for these classes instead of individual trajectories.
However, we did not find such classes (see online Supplementary
Appendix 1) and thus carried out the analysis at an individual level.
Next, we reparameterised the model so that the slope repre-
sented change over the first seven appointments rather than
between the first and the second appointments as in the basic
model (note that all 20 appointments were still used to estimate
this model). We chose to report the symptomatic change in the
first seven appointments because it is the average number of
appointments nationally and thus represents a typical length of
therapeutic intervention within IAPT (Public Health England,
2019). We detail the model in online Supplementary Appendix 2.
Additional analytical complexity stemmed from the multilevel
structure of the data (multiple patients received therapy from the
same therapist). Accounting for this analytically provides
unbiased treatment response trajectories. In addition, it allowed
us to assess variables associated with the average rate of symptom-
atic change for each therapist’s patients. Additional details are
provided in online Supplementary Appendix 3.
We then added variables considered to be related to the inter-
cepts (baseline symptom severity) and slopes (rate of symptomatic
change) of treatment response trajectories to the reparameterised
model. At the patient level (the within-level part of the model), we
included gender, age, socioeconomic status, and baseline level of
functioning (WSAS). We included therapy intensity (low v.
high) as an important covariate accounting for different thera-
peutic approaches applied for low- and high-intensity IAPT
patients. Therapy frequency was considered only in the context
of the slope as its association with the intercept would be concep-
tually non-sensical. We also explored the association between
baseline symptom severity and rate of symptomatic change. At
the therapist level (the between-level part of model), we examined
whether caseload was associated with (a) the average rate of symp-
tomatic change and (b) recovery for each therapist’s patients.
We used a multilevel logit model for variables associated with
the binary clinical endpoint of symptomatic recovery. The set of
variables examined in relation to symptomatic recovery was iden-
tical to that of rate of symptomatic change except that (a) we
included baseline symptom severity of both depression and anx-
iety (as recovery in IAPT requires having scores below correspond-
ing threshold on both measures) and (b) these baseline symptom†The notes appear after the main text.
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severities were operationalised as total scores of PHQ-9 and GAD-7
at initial assessment (i.e. not as intercepts of treatment response tra-
jectories). Total PHQ-9 and GAD-7 scores at baseline were moder-
ately correlated (r = 0.46), allowing inclusion of both variables in the
same model. We bootstrapped the model (1000 iterations) to obtain
bootstrapped confidence intervals (CIs) for odds ratios. We con-
ducted all analyses in MPlus 8.4 (Muthén & Muthén, 1998-2019)
and R 3.6.3 (R Core Team, 2019).
The script for our analyses and synthetic data are available at
https://osf.io/48eur/.
Results
Sample and variable descriptives
Table 1 provides the sociodemographic characteristics and basic
descriptive statistics of variables hypothesised to be associated
with outcomes.
Growth models
The basic nonlinear growth models fit the data well (PHQ-9:
RMSEA = 0.034, CFI = 0.952, TLI = 0.955, SRMR = 0.082;
GAD-7: RMSEA = 0.032, CFI = 0.951, TLI = 0.954, SRMR =
0.080). Figure 1 depicts the estimated mean trajectories for
the two scales. The modelled mean baseline symptom severity
(intercept) had a value of 13.5 for the PHQ-9 and 12.6 for the
GAD-7. The mean slopes (−0.9 for the PHQ-9 and −0.8 for the
GAD-7) reflect the average change in scores between the first
and second therapy sessions. Such interpretation is not very
informative with regards to understanding improvement over
the course of the therapy. In the reparameterised growth
model, the slopes represent change over the first seven sessions.
Results suggest that the average improvement across seven
therapy sessions is 4.2 points on the PHQ-9 and 4.0 points
on the GAD-7 (see online Supplementary Appendix 2 for
details).
Table 1. Sample characteristics and descriptive statistics for variables hypothesised to be associated with outcomes
Full sample (n = 28 810) Recovery subsample (n = 8114)
Gender: count (%) Females = 19 191 (66.6) Females = 5378 (66.3)
Males = 9462 (32.8) Males = 2736 (33.7)
Missing = 157 (0.6) Missing = 0 (0)
Age: mean (S.D.) 41.3 (15.3) 39.4 (13.3)
Functioning (WSAS): mean (S.D.) 19.2 (9.1) 20.0 (8.6)
Socioeconomic status (median IMD): mean (S.D.) 6.3 (2.0) 6.4 (1.9)
Therapy intensity: count (%) Low = 17 189 (59.7)a Low = 5037 (62.1)
High = 10 884 (37.8)a High = 3077 (37.9)
Missing = 737 (2.5) Missing = 0 (0)
Therapy frequency (gap between therapies in days): median (IQR) 14.0 (12.5) 14.0 (10)
Baseline symptom severity PHQ-9: mean (S.D.) 13.6 (6.3) 14.7 (5.3)
Baseline symptom severity GAD-7: mean (S.D.) 12.6 (5.3) 14.0 (4.1)
Number of patients per therapist: median (IQR) 29 (80.8) 52 (84)
Ethnicity: count (%) White = 25 254 (87.6) White = 6538 (80.6)
Indian = 334 (1.2) Indian = 131 (1.6)
Asian = 238 (0.8) Asian = 86 (1.1)
Black = 206 (0.7) Black = 63 (0.8)
Mixed/other = 717 (2.5) Mixed/other = 235 (2.9)
Missing = 2061 (7.2) Missing = 1061 (13.0)
Diagnosis: count (%) Depression = 11 194 (38.9) Depression = 3096 (38.2)
Anxiety = 9219 (32.0) Anxiety = 2562 (31.6)
OCD = 839 (2.9) OCD = 270 (3.3)
PTSD = 1166 (4.0) PTSD = 304 (3.8)
Panic disorder = 791 (2.7) Panic disorder = 252 (3.1)
Phobia = 1084 (3.8) Phobia = 294 (3.6)
Other/unspecified = 636 (2.2) Other/unspecified = 239 (2.9)
Missing = 3881 (13.5) Missing = 1097 (13.5)
OCD, obsessive-compulsive disorder; PTSD, post-traumatic stress disorder.
aOf those initially assigned to low or high intensity therapy 9544 individuals (33.1%) were stepped up or down in intensity during the therapy course.
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Variables associated with baseline symptom severity and rate
of symptomatic change
Tables 2 and 3 include estimated regression coefficients (including
standardised estimates) for depression and anxiety symptoms,
respectively.
Variables associated with baseline symptom severity and rate of
symptomatic change for depression (PHQ-9)
Patients’ modelled baseline symptom severity (the within-level
intercept of their treatment response trajectory) was significantly
related to gender (females have greater baseline symptom sever-
ity), age (younger patients have greater baseline symptom sever-
ity), baseline functioning (patients with more functional
impairment have greater baseline symptom severity), socio-
economic status (patients living in areas of higher deprivation
have greater baseline symptom severity), and therapy intensity.
The significant positive relationship between baseline symptom
severity and therapy intensity confirms that patients with more
severe depression symptoms tend to be assigned to high-intensity
therapy. In terms of standardised coefficients, baseline symptom
Fig. 1. Estimated average growth model trajectories for PHQ-9 (blue) and GAD-7 (red). Scale score is computed as sum score of all items.
Table 2. Regression coefficients for conditional multilevel growth model of depressive symptoms









BSS Genderb −0.401 (0.081) −0.034 (0.007) <0.001
BSS Age −0.021 (0.003) −0.051 (0.007) <0.001
BSS Functioning (WSAS) 0.337 (0.005) 0.547 (0.007) <0.001
BSS Socioeconomic status (median IMD) −0.177 (0.026) −0.061 (0.009) <0.001
BSS Therapy intensity 0.374 (0.103) 0.032 (0.009) <0.001
RoSCh Genderb −0.190 (0.073) −0.025 (0.010) 0.009
RoSCh Age −0.017 (0.003) −0.063 (0.011) <0.001
RoSCh Functioning (WSAS) 0.022 (0.005) 0.055 (0.013) <0.001
RoSCh Socioeconomic status (median IMD) 0.068 (0.032) 0.037 (0.017) 0.037
RoSCh Therapy intensity −0.005 (0.090) −0.001 (0.012) 0.960
RoSCh Therapy frequency 0.002 (0.006) 0.010 (0.026) 0.681
RoSCh Baseline symptom severity
(Intercepts within)
−0.252 (0.013) −0.393 (0.014) <0.001
Therapist level
(between)
RoSCh Number of patients −0.005 (0.003) −0.319 (0.153) 0.037
RoSCh, rate of symptomatic change (where more negative slopes indicate more rapid improvement); BSS, baseline symptom severity.
R2: RoSCh = 0.138, BSS = 0.321.
aAll independent variables are cross-adjusted.
bReference group = females.
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severity had the strongest relationship with baseline functioning
scores.
Patients’ rate of symptomatic change for depression (the
within-level slope of patients’ treatment response trajectories)
was most strongly related (in terms of magnitude of impact) to
their baseline depression severity. More specifically, the higher
the baseline symptom severity, the faster the improvement.
Additionally, the rate of symptomatic change was related to gen-
der (males improve more rapidly), age (older patients improve
more rapidly), baseline level of functioning (patients with less
functional impairment improve more rapidly), and socio-
economic status (patients living in areas of higher deprivation
improve more rapidly). The improvement rate was not signifi-
cantly related to therapy frequency or intensity.
The average improvement of a particular therapist’s
patients (the between-level part of the model), was signifi-
cantly related to that therapist’s caseload, however, in an unex-
pected direction – a larger caseload was related to more rapid
improvement.
Variables associated with baseline symptom severity and rate of
symptomatic change for anxiety (GAD-7)
Results for the GAD-7 treatment response trajectories were simi-
lar to those of the PHQ-9. However, contrary to the PHQ-9
results, the relationship between baseline symptom severity and
therapy intensity was at the borderline of statistical significance
and was in the opposite direction than for depression.
Furthermore, gender and socioeconomic status were not related
to the rate of improvement for GAD-7 scores. Finally, considering
the standardised coefficients, functioning had a larger effect size
for anxiety than for depression (with lower impairment related
to more rapid improvement), when controlling for all other
variables.
Variables associated with symptomatic recovery
Table 4 shows results of a multilevel logit model with symptom-
atic recovery as the outcome. Baseline symptom severity, age, and
baseline level of functioning were significantly related to symp-
tomatic recovery, even when bootstrap was applied. Specifically,
with each additional point on the PHQ-9 or GAD-7 at the begin-
ning of therapy, the chances of symptomatic recovery decrease by
approximately 5.8% and 6.3%, respectively. Similarly, an increase
of one point on the WSAS is associated with an approximate 2.4%
reduction in chances of recovery. Each additional year of age
increases odds of recovery by approximately 0.8%.
Therapy intensity and frequency were significantly related to
symptomatic recovery; however, bootstrapped odds ratios were
not and thus the results should be interpreted with caution. In
addition, both variables have a relatively small effect on recovery.
For example, an increase of a day in the median number of days
between sessions reduced the probability of recovery by 0.7% and
being assigned to high-intensity therapy lowered chances of
recovery by approximately 11.2% when adjusting for all other
variables (it is important to note, however, that high-intensity
therapists generally see more complex and severe patients).
Socioeconomic status, gender, and therapist caseload were not
significantly associated with symptomatic recovery.
The results for the sample including those individuals who had
not yet completed therapy or who had dropped out (whose symp-
tomatic recovery was derived from the last recorded session) are
presented in online Supplementary Appendix 4. They were very
similar to those presented in Table 4.
Discussion
In this study, we explored which sociodemographic, clinical, and
therapeutic variables may be related to (1) baseline symptom
Table 3. Regression coefficients for conditional multilevel growth model of anxiety symptoms









BSS Genderb −0.937 (0.072) −0.095 (0.007) <0.001
BSS Age −0.036 (0.003) −0.102 (0.008) <0.001
BSS Functioning (WSAS) 0.207 (0.004) 0.403 (0.008) <0.001
BSS Socioeconomic status (median IMD) −0.115 (0.024) −0.048 (0.010) <0.001
BSS Therapy intensity −0.193 (0.097) −0.020 (0.010) 0.048
RoSCh Genderb −0.092 (0.063) −0.014 (0.010) 0.145
RoSCh Age −0.014 (0.003) −0.058 (0.010) <0.001
RoSCh Functioning (WSAS) 0.044 (0.004) 0.126 (0.012) <0.001
RoSCh Socioeconomic status (median IMD) 0.013 (0.024) 0.008 (0.015) 0.577
RoSCh Therapy intensity 0.005 (0.088) 0.001 (0.013) 0.955
RoSCh Therapy frequency 0.008 (0.005) 0.042 (0.025) 0.091
RoSCh Baseline symptom severity
(Intercepts within)
−0.262 (0.012) −0.388 (0.012) <0.001
Therapist level
(between)
RoSCh Number of patients −0.006 (0.002) −0.322 (0.092) 0.001
RoSCh, rate of symptomatic change (where more negative slopes indicate more rapid improvement); BSS, baseline symptom severity.
R2: RoSCh = 0.127, BSS = 0.188.
aAll independent variables are cross-adjusted.
bReference group = females.
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severity, (2) rate of symptomatic change, and (3) symptomatic
recovery (as defined by IAPT criteria) for patients with depression
and/or anxiety engaging in psychological therapy in IAPT ser-
vices. Importantly, our predictors were all variables that
are routinely collected in IAPT services, including individual vari-
ables (gender, age, andsocioeconomic status), clinical variables
(baseline depression and anxiety scores, and baseline level of
functioning), and therapeutic variables [therapy intensity and
median number of days between sessions (i.e. frequency)]. Our
multilevel approach also allowed us to test the relationship
between therapists’ IAPT caseload and the average rate of symp-
tomatic change and recovery of their corresponding patients.
Treatment response trajectories
Although baseline severity of both depression and anxiety symp-
toms was significantly related to all included variables (i.e. gender,
age, baseline functioning, socioeconomic status, and therapy inten-
sity), baseline functioning had by far the largest effect sizes
(whereby greater functional impairment was associated with more
severe symptomatology). Age, baseline functioning, baseline symp-
tom severity, and therapist caseload were significantly related to the
rate of change for both depression and anxiety symptoms, and gen-
der and socioeconomic status were additionally related to rate of
change for depression (but not anxiety) symptoms. Therapy charac-
teristics such as intensity and frequency seemed to have no relation
to the rate of symptomatic change. Baseline symptom severity was
the most important variable associated with rate of change for both
depression and anxiety symptoms, whereby patients with more
severe symptomatology at the start of therapy improved more rap-
idly. On average, a 1-point difference in total score on the corre-
sponding scale between two patients at baseline results in an
expected difference of 0.748 (i.e. 1− 0.252) points on the PHQ-9
and 0.738 (i.e. 1− 0.262) points on the GAD-7 between them at
seventh session. Baseline functioning was the only other variable
to show a clinically-relevant effect size at the individual level
(whereby greater functional impairment at the start of therapy
was related to slower improvement), but only for anxiety symptoms.
Our finding that greater baseline severity of depression and
anxiety symptoms was associated with more rapid symptom
improvement is unusual. In general, others have found either
that baseline severity negatively impacts the rate of symptomatic
improvement [e.g. Sunderland et al.’s (2012) study of online
CBT for depression and anxiety disorders] or has no relationship
[e.g. Comninos & Grenyer’s (2007) study of early rapid response
in supportive-expressive dynamic psychotherapy for major
depression]. The importance of baseline symptom severity
extends beyond symptomatic change, as Hodgekins et al. (2015)
demonstrated in their finding that baseline severity of psychotic
symptoms serves as a predictor of belonging to a ‘poorer’ trajec-
tory of social recovery for patients with first episode psychosis.
We located only one study that reflected our finding that base-
line severity was positively related to the rate of symptomatic
improvement [Elliott et al.’s (2005) study of veterans receiving
treatment for PTSD]. It is conceivable that help-seeking indivi-
duals with higher baseline symptom severity may be more moti-
vated to engage with therapy in an effort to overcome more severe
symptoms (’the gift of desperation’) and that increased engage-
ment positively impacts treatment outcomes (Dixon et al.,
2016). However, this explanation is perhaps more reasonable for
anxiety symptoms than depression symptoms, wherein greater
severity may instead be a barrier to engagement. Furthermore,
it is important to consider the potential for statistical artefacts
when interpreting these effect sizes, as patients starting with
more severe symptoms have greater scope for improvement.
Our finding about the negative impact of functional impairment
on rate of symptomatic improvement is more consistent with the
literature. For example, Lutz et al.’s (2014) study of CBT for patients
with panic disorder highlighted the importance of social function-
ing in predicting class membership (as characterised in part by rate
of symptomatic change). Poor functioning is a well-documented
barrier to symptomatic improvement. Many people with greater
functional impairment are unemployed and/or have fewer social
contacts, and thus are missing two key protective factors associated
with positive mental health. Poor functioning is further related to
barriers in engaging with therapy. For example, poorer functioning
may equate to fewer resources for use in therapy or poor attendance
(due to various reasons including financial or social difficulties and
anxiety). Thus, interventions for those with poorer social function-
ing may require additional considerations, such as strategies for
returning to work or building up social networks and overcoming
barriers related to each of these goals (Knight et al., 2020).
At the therapist level, our finding that a larger therapist case-
load was associated with more rapid improvement could indicate












Baseline symptom severity PHQ-9 −0.060 (0.007) 0.942 <0.001 0.940 (0.922–0.958)
Baseline symptom severity GAD-7 −0.065 (0.007) 0.937 <0.001 0.935 (0.916–0.953)
Gender 0.076 (0.049) 1.079 0.138 1.090 (0.947–1.248)
Age 0.008 (0.002) 1.008 <0.001 1.008 (1.003–1.014)
Functioning (WSAS) −0.024 (0.003) 0.976 <0.001 0.975 (0.966–0.985)
Therapy frequency −0.008 (0.003) 0.992 0.015 0.994 (0.985–1.003)
Therapy intensity −0.119 (0.060) 0.888 0.034 0.886 (0.748–1.048)
Socioeconomic status (median IMD) −0.021 (0.016) 0.979 0.180 0.985 (0.941–1.033)
Therapist level
(between)
Number of patients 0.000 (0.001) 1.000 0.446 1.001 (0.999–1.002)
aAll independent variables were cross-adjusted.
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that more frequent application of IAPT techniques facilitates
greater therapist competency. Alternatively, this could simply
indicate that more competent therapists are assigned more
patients. In either case, this result should not be interpreted caus-
ally. First, the caseload variable represents only the number of
IAPT patients seen by each therapist and is not weighted for
the number of days worked in IAPT. It is possible that each ther-
apist sees additional patients outside of IAPT, in which case the
effect of total caseload would be unmeasured in our analyses.
Second, some IAPT therapists focus on specific groups of patients
(e.g. patients with long-term physical conditions), which could
affect their caseload and potentially bias results; however, this spe-
cialisation applies to a relatively small group of therapists.
Symptomatic recovery
Higher chance of symptomatic recovery, as defined by IAPT cri-
teria, was associated with lower baseline severity of depression
and anxiety symptoms, lower functional impairment, and
increased age, with baseline symptom severity having the greatest
effect. These findings are not particularly surprising: while start-
ing therapy with a higher score on the PHQ-9/GAD-7 enables
more scope for improvement (hence the sensibility of its associ-
ation with faster symptomatic improvement), it also implies a fur-
ther distance to IAPT’s recovery threshold. Several other studies
have found similar results in terms of baseline symptom severity
(Amati et al., 2018; Marttunen et al., 2008), including two within
the IAPT setting (Green et al., 2015; Gyani et al., 2013a, 2013b).
These patients may be at increased risk for additional psychiatric
comorbidities, including psychotic experiences (Stochl et al.,
2015), which could further contribute to the reduced chance of
recovery (Knight et al., 2020).
In interpreting our results, it must be acknowledged that peo-
ple with ‘less favourable’ characteristics (e.g. those with higher
baseline symptom severity/functional impairment) do not neces-
sarily benefit less from therapy. It is important to remember that
the definition of symptomatic recovery (as routinely used in IAPT
for performance monitoring purposes) is centred around absolute
improvement (i.e. whether their symptoms were reduced beyond
the recovery ‘threshold’) rather than relative improvement (i.e.
the difference between baseline and final symptom severity).
Hence, in order to be most informative, results about symptom-
atic recovery should be contextualised within our discussion of
treatment response trajectory.
Strengths and limitations
The main strength of this study is the large clinical sample.
Furthermore, although this is not the first study that has explored
variables related to symptomatic improvement and recovery in the
context of psychological therapy, we used an analytical approach
that is more appropriate for the complex data structure of longi-
tudinal outcomes nested under therapists. A further strength is
the applicability to clinical settings in general, and to the IAPT
setting in particular, as we used routinely-collected, easily-
obtained measures in our analyses. However, this may also be
considered as a weakness, as many potentially relevant variables
were not available for inclusion in our analyses, including medi-
cation use, treatment history, therapist competence, and thera-
peutic alliance, as well as other key risk and protective factors.
The absence of such prognostic variables can be seen in the rela-
tively low R2 values for our models.
We acknowledge additional limitations in terms of sample selec-
tion and available variables. The selection of referrals meeting IAPT
service criteria for treatment may have introduced Berkson’s bias
into our analyses, particularly in those regarding recovery. We
were unable to quantify this bias because we have no recovery
data for referrals not admitted to IAPT. Furthermore, the sub-
sample of 8114 with the requisite data for evaluation of predictors
of recovery may not be representative of the full sample as patients
drop out for non-random reasons; again, this is inherent in many
clinical samples where drop-outs may be due to recovery or
worsening of symptoms. Therefore, inferences from these findings
need to be made with caution. Finally, although our sample size was
large, it represented only two mental health trusts, which may limit
the generalisability of our results.
In terms of limitations relating to individual variables, we
could not investigate relationship between ethnicity and treatment
response trajectories as we had very few Black, Asian, and
Minority Ethnic (BAME) individuals in our sample (although
this broadly reflects the proportion of BAME patients accessing
IAPT nationally). Although beyond the scope of this paper, the
low proportion of BAME individuals accessing IAPT services
merits careful consideration. Low participation may be due to a
number of causes, including individual factors (e.g. personal atti-
tudes towards services), service-level factors (e.g. inaccessibility or
unacceptability), and wider cultural issues (e.g. discrimination
and stigma). Furthermore, our calculation of socioeconomic sta-
tus has limitations; as IAPT does not collect this information
on an individual level, we derived this variable by using the out-
ward code of each individual’s postcode to calculate the median
IMD decile for the area, which may not be representative of an
individual’s experience. Finally, in terms of caseload, we were
only able to identify the number of patients the therapist sees
within the IAPT setting. Yet, it is not uncommon for IAPT thera-
pists to see additional patients outside of IAPT.
Conclusions
Therapist confidence and self-efficacy are important factors for
determining therapy effectiveness (Green et al., 2014; Heinonen,
Lindfors, Laaksonen, & Knekt, 2012). Equally as important,
patients’ positive expectations of therapy outcome have been con-
sistently linked to better actual outcomes (Mondloch, Cole, &
Frank, 2001). Although therapists and patients may worry about
progress and outcomes in the context of more severe baseline
symptomatology, our findings suggest that they can take courage
in the knowledge that more ‘unwell’ patients actually have the
potential to improve more rapidly. Moreover, this finding demon-
strates the gains possible for patients with more severe depression
and anxiety in services offering short-term psychological therapies.
Furthermore, our results regarding variables associated with
symptomatic recovery are useful for highlighting groups of
patients that may benefit from additional or more intensive inter-
vention. One such group consists of patients who begin therapy
with more severe depression and/or anxiety symptoms and poorer
functioning, as these two characteristics have a significant nega-
tive impact on symptomatic recovery. In order to ensure that
everyone has the potential to reach the IAPT symptomatic recov-
ery threshold, we must continue to investigate how to best tailor
interventions to fit individual patients’ needs.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0033291720005395.
8 Jan Stochl et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291720005395
Downloaded from https://www.cambridge.org/core. University of Dundee Library & Learning Centre, on 18 Mar 2021 at 11:48:55, subject to the Cambridge Core terms of use, available at
Acknowledgements. We are extremely grateful to IAPT service for provid-
ing us with data. We thank Dr James Kirkbride for his expert advice on how to
derive socioeconomic status from the limited information in the data available
to us.
Financial support. This paper presents independent research funded by the
National Institute for Health Research (NIHR) under its Programme Grants
for Applied Research Programme (Reference Number RP-PG-0616-20003).
JS, JP, and PBJ received support from the NIHR Applied Research
Collaboration (ARC) East of England (EoE) at the Cambridgeshire and
Peterborough NHS Foundation Trust. ES is supported by a Gates
Cambridge Scholarship. JF is funded by the Medical Research Council
Doctoral Training/Sackler Fund and the Pinsent Darwin Fund. The views
expressed are those of the author(s) and not necessarily those of the NHS,
the NIHR, the Department of Health and Social Care, the MRC or the
Gates Cambridge Trust.
Conflict of interest. JS discloses consultancy for IESO digital health. The
remaining authors have no conflicts of interest.
Note
1 In response to a suggestion following peer review, we have also analysed the
sample that included individuals who had not completed treatment and whose
symptomatic recovery was derived from the last recorded session. The results
are presented in Appendix 4.
References
Ali, S., Littlewood, E., McMillan, D., Delgadillo, J., Miranda, A., Croudace, T.,
& Gilbody, S. (2014). Heterogeneity in patient-reported outcomes following
low-intensity mental health interventions: A multilevel analysis. PLoS ONE,
9(9), e99658. doi:10.1371/journal.pone.0099658.
Amati, F., Banks, C., Greenfield, G., & Green, J. (2018). Predictors of outcomes
for patients with common mental health disorders receiving psychological
therapies in community settings: A systematic review. Journal of Public
Health, 40(3), e375–e387. doi:10.1093/pubmed/fdx168.
Barth, J., Munder, T., Gerger, H., Nüesch, E., Trelle, S., Znoj, H., … Cuijpers,
P. (2013). Comparative efficacy of seven psychotherapeutic interventions for
patients with depression: A network meta-analysis. PLoS Medicine, 10(5),
e1001454. doi:10.1371/journal.pmed.1001454.
Bucher, M. A., Suzuki, T., & Samuel, D. B. (2019). A meta-analytic review of
personality traits and their associations with mental health treatment out-
comes. Clinical Psychology Review, 70(July 2018), 51–63. doi:10.1016/
j.cpr.2019.04.002.
Cameron, I. M., Crawford, J. R., Lawton, K., & Reid, I. C. (2008). Psychometric
comparison of PHQ-9 and HADS for measuring depression severity in pri-
mary care. British Journal of General Practice, 58(546), 32–36. doi:10.3399/
bjgp08X263794.
Clark, D. M. (2018). Realizing the mass public benefit of evidence-based psy-
chological therapies: The IAPT program. Annual Review of Clinical
Psychology, 14, 159–183. doi:10.1146/annurev-clinpsy-050817-084833.
Clark, D. M., Canvin, L., Green, J., Layard, R., Pilling, S., & Janecka, M. (2018).
Transparency about the outcomes of mental health services (IAPT
approach): An analysis of public data. Lancet, 391(10121), 679–686.
doi:10.1016/S0140-6736(17)32133-5.
Comninos, A., & Grenyer, B. F. S. (2007). The influence of interpersonal fac-
tors on the speed of recovery from major depression. Psychotherapy
Research, 17(2), 239–249. doi:10.1080/10503300600849140.
Cristea, I. A., Gentili, C., Cotet, C. D., Palomba, D., Barbui, C., & Cuijpers, P.
(2017). Efficacy of psychotherapies for borderline personality disorder: A
systematic review and meta-analysis. JAMA Psychiatry, 74(4), 319–328.
https://doi.org/10.1001/jamapsychiatry.2016.4287.
Cuijpers, P., Cristea, I. A., Karyotaki, E., Reijnders, M., & Huibers, M. J. H.
(2016). How effective are cognitive behavior therapies for major depression
and anxiety disorders? A meta-analytic update of the evidence. World
Psychiatry, 15(3), 245–258. https://doi.org/10.1002/wps.20346.
Cuijpers, P., Karyotaki, E., Weitz, E., Andersson, G., Hollon, S. D., & Van
Straten, A. (2014a). The effects of psychotherapies for major depression
in adults on remission, recovery and improvement: A meta-analysis.
Journal of Affective Disorders, 159, 118–126. https://doi.org/10.1016/j.jad.
2014.02.026.
Cuijpers, P., Van Lier, P. A. C., Van Straten, A., & Donker, M. (2005).
Examining differential effects of psychological treatment of depressive dis-
order: An application of trajectory analyses. Journal of Affective Disorders,
89(1-3), 137–146. doi:10.1016/j.jad.2005.09.001.
Cuijpers, P., Weitz, E., Twisk, J., Kuehner, C., Cristea, I., David, D., … Hollon,
S. D. (2014b). Gender as predictor and moderator of outcome in cognitive
behavior therapy and pharmacotherapy for adult depression: An ‘individual
patient data’ meta-analysis. Depression and Anxiety, 31(11), 941–951.
doi:10.1002/da.22328.
Del Re, A. C., Flückiger, C., Horvath, A. O., Symonds, D., & Wampold, B. E.
(2012). Therapist effects in the therapeutic alliance-outcome relationship: A
restricted-maximum likelihood meta-analysis. Clinical Psychology Review,
32(7), 642–649. doi:10.1016/j.cpr.2012.07.002.
Dixon, L. B., Holoshitz, Y., & Nossel, I. (2016). Treatment engagement of indi-
viduals experiencing mental illness: Review and update. World Psychiatry,
15(1), 13–20. doi:10.1002/wps.20306.
Elliott, P., Biddle, D., Hawthorne, G., Forbes, D., & Creamer, M. (2005).
Patterns of treatment response in chronic posttraumatic stress disorder:
An application of latent growth mixture modeling. Journal of Traumatic
Stress, 18(4), 303–311. doi:10.1002/jts.20041.
Flückiger, C., Grosse Holtforth, M., Znoj, H. J., Caspar, F., & Wampold, B. E.
(2013). Is the relation between early post-session reports and treatment out-
come an epiphenomenon of intake distress and early response? A multi-
predictor analysis in outpatient psychotherapy. Psychotherapy Research, 23
(1), 1–13. doi:10.1080/10503307.2012.693773.
Goddard, E., Wingrove, J., & Moran, P. (2015). The impact of comorbid person-
ality difficulties on response to IAPT treatment for depression and anxiety.
Behaviour Research and Therapy, 73, 1–7. doi:10.1016/j.brat.2015.07.006.
Green, H., Barkham, M., Kellett, S., & Saxon, D. (2014). Therapist effects and
IAPT Psychological Wellbeing Practitioners (PWPs): A multilevel model-
ling and mixed methods analysis. Behaviour Research and Therapy, 63,
43–54. doi:10.1016/j.brat.2014.08.009.
Green, S. A., Honeybourne, E., Chalkley, S. R., Poots, A. J., Woodcock, T.,
Price, G., … Green, J. (2015). A retrospective observational analysis to iden-
tify patient and treatment-related predictors of outcomes in a community
mental health programme. BMJ Open, 5(5), e006103. doi:10.1136/
bmjopen-2014-006103.
Gunn, J., Densley, K., Middleton, A., Ambresin, G., Dowrick, C., Hegarty, K.,
… Herrman, H. (2013). A trajectory-based approach to understand the fac-
tors associated with persistent depressive symptoms in primary care.
Journal of Affective Disorders, 148(2-3), 338–346. doi:10.1016/
j.jad.2012.12.021.
Gyani, A., Shafran, R., Layard, R., & Clark, D. M. (2013a). Behaviour research and
therapy enhancing recovery rates: Lessons from year one of IAPT. Behaviour
Research and Therapy, 51(9), 597–606. doi:10.1016/j.brat.2013.06.004.
Gyani, A., Shafran, R., Layard, R., & Clark, D. M. (2013b). Enhancing recovery
rates: Lessons from year one of IAPT. Behaviour Research and Therapy, 51
(9), 597–606. doi:10.1016/j.brat.2013.06.004.
Heinonen, E., Lindfors, O., Laaksonen, M. A., & Knekt, P. (2012). Therapists’
professional and personal characteristics as predictors of outcome in short-
and long-term psychotherapy. Journal of Affective Disorders, 138(3), 301–
312. doi:10.1016/j.jad.2012.01.023.
Hodgekins, J., Birchwood, M., Christopher, R., Marshall, M., Coker, S., Everard,
L., … Fowler, D. (2015). Investigating trajectories of social recovery in indivi-
duals with first-episode psychosis: A latent class growth analysis. British
Journal of Psychiatry, 207(6), 536–543. doi:10.1192/bjp.bp.114.153486.
Horvath, A. O., Del Re, A. C., Flückiger, C., & Symonds, D. (2011). Alliance in
individual psychotherapy. Psychotherapy, 48(1), 9–16. doi:10.1037/a0022186.
Knight, C., Russo, D. A., Stochl, J., Croudace, T. J., Fowler, D., Grey, N., …
Perez, J. (2020). Prevalence of and recovery from common mental disorder
including psychotic experiences in the UK primary care improving access to




Downloaded from https://www.cambridge.org/core. University of Dundee Library & Learning Centre, on 18 Mar 2021 at 11:48:55, subject to the Cambridge Core terms of use, available at
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9 – validity
of a brief depression severity measure. Journal of General Internal Medicine,
16(9), 606–613. doi:10.1046/j.1525-1497.2001.016009606.x.
Laaksonen, M. A., Knekt, P., & Lindfors, O. (2013a). Psychological predictors
of the recovery from mood or anxiety disorder in short-term and long-term
psychotherapy during a 3-year follow-up. Psychiatry Research, 208(2), 162–
173. doi:10.1016/j.psychres.2012.09.053.
Laaksonen, M. A., Knekt, P., Sares-Jäske, L., & Lindfors, O. (2013b). Psychological
predictors on the outcome of short-term psychodynamic psychotherapy and
solution-focused therapy in the treatment of mood and anxiety disorder.
European Psychiatry, 28(2), 117–124. doi:10.1016/j.eurpsy.2011.12.002.
Lambert, M. J. (2013). Outcome in psychotherapy: The past and important
advances. Psychotherapy, 50(1), 42–51. https://doi.org/10.1037/a0030682.
Lindfors, O., Ojanen, S., Jääskeläinen, T., & Knekt, P. (2014). Social support as
a predictor of the outcome of depressive and anxiety disorder in short-term and
long-term psychotherapy. Psychiatry Research, 216(1), 44–51. doi:10.1016/
j.psychres.2013.12.050.
Lutz, W., Hofmann, S. G., Rubel, J., Boswell, J. F., Shear, M. K., Gorman, J. M.,…
Barlow, D. H. (2014). Patterns of early change and their relationship to out-
come and early treatment termination in patients with panic disorder. Journal
of Consulting and Clinical Psychology, 82(2), 287–297. doi:10.1037/a0035535.
Lutz,W.,Martinovich, Z., Lyons, J. S., Leon, S. C., & Stiles,W. B. (2007). Therapist
effects in outpatient psychotherapy: A three-level growth curve approach.
Journal of Counseling Psychology, 54(1), 32. doi:10.1037/0022-0167.54.1.32.
Lutz, W., Stulz, N., & Kock, K. (2009). Patterns of early change and their relation-
ship to outcome and follow-up among patients with major depressive disorders.
Journal of Affective Disorders, 118(1-3), 60–68. doi:10.1016/j.jad.2009.01.019.
Manea, L., Gilbody, S., & McMillan, D. (2012). Optimal cut-off score for diag-
nosing depression with the Patient Health Questionnaire (PHQ-9): A
meta-analysis. Canadian Medical Association Journal, 184(3), E191–E196.
doi:10.1503/cmaj.110829.
Marttunen, M., Välikoski, M., Lindfors, O., Laaksonen, M. A., & Knekt, P.
(2008). Pretreatment clinical and psychosocial predictors of remission
from depression after short-term psychodynamic psychotherapy and
solution-focused therapy: A 1-year follow-up study. Psychotherapy
Research, 18(2), 191–199. doi:10.1080/10503300701429958.
Mondloch, M. V., Cole, D. C., & Frank, J. W. (2001). Does how you do depend
on how you think you’ll do? A systemic review of the evidence for a relation
between patients’ recovery expectations and health outcomes. Canadian
Medical Association Journal, 165(10), 1303–1303.
Mundt, J. C., Marks, I. M., Shear, M. K., & Greist, J. H. (2002). The work and
social adjustment scale: A simple measure of impairment in functioning.
British Journal of Psychiatry, 180, 461–464. doi:10.1192/bjp.180.5.461.
Muthén, L. K., & Muthén, B. O. (1998-2019). Mplus user’s guide, 8th Edn. Los
Angeles, CA: Muthén & Muthén.
National Collaborating Centre for Mental Health. (2018). The Improving Access
to Psychological Therapies Manual. Retrieved from https://www.england.nhs.
uk/publication/the-improving-access-to-psychological-therapies-manual/.
Nissen-Lie, H. A., Monsen, J. T., Ulleberg, P., & Rønnestad, M. H. (2013).
Psychotherapists’ self-reports of their interpersonal functioning and diffi-
culties in practice as predictors of patient outcome. Psychotherapy
Research, 23(1), 86–104. doi:10.1080/10503307.2012.735775.
Norcross, J. C., & Wampold, B. E. (2011). What works for whom: Tailoring
psychotherapy to the person. Journal of Clinical Psychology, 67(2), 127–
132. doi:10.1002/jclp.20764.
Porter, E., & Chambless, D. L. (2015). A systematic review of predictors and
moderators of improvement in cognitive-behavioral therapy for panic disorder
and agoraphobia. Clinical Psychology Review, 42, 179–192. doi:10.1016/
j.cpr.2015.09.004.
Public Health England. (2019). Public Health Profiles. Retrieved from https://
fingertips.phe.org.uk/search/IAPT.
R Core Team. (2019). R: A language and environment for statistical comput-
ing. R Foundation for Statistical Computing. Vienna, Austria. Retrieved
from https://www.R-project.org.
Robinson, L., Kellett, S., & Delgadillo, J. (2020). Dose-response patterns in
low and high intensity cognitive behavioral therapy for common mental
health problems. Depression and Anxiety, 37(3), 285–294. doi:10.1002/
da.22999.
Saxon, D., Firth, N., & Barkham, M. (2017). The relationship between ther-
apist effects and therapy delivery factors: Therapy modality, dosage, and
non-completion. Administration and Policy in Mental Health and
Mental Health Services Research, 44(5), 705–715. doi:10.1007/
s10488-016-0750-5.
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Lowe, B. (2006). A brief meas-
ure for assessing generalized anxiety disorder – The GAD-7. Archives of
Internal Medicine, 166(10), 1092–1097. doi:10.1001/archinte.166.10.1092.
Stein, N. R., Dickstein, B. D., Schuster, J., Litz, B. T., & Resick, P. A. (2012).
Trajectories of response to treatment for posttraumatic stress disorder.
Behavior Therapy, 43(4), 790–800. doi:10.1016/j.beth.2012.04.003.
Stochl, J., Jones, P. B., Plaistow, J., Reininghaus, U., Priebe, S., Perez, J., &
Croudace, T. J. (2014). Multilevel ordinal factor analysis of the positive
and negative syndrome scale (PANSS). International Journal of Methods
in Psychiatric Research, 23(1), 25–35. doi:10.1002/mpr.1429.
Stochl, J., Khandaker, G. M., Lewis, G., Perez, J., Goodyer, I. M., Zammit, S.,…
Jones, P. B. (2015). Mood, anxiety and psychotic phenomena measure a
common psychopathological factor. Psychological Medicine, 45(7), 1483–
1493. doi:10.1017/S003329171400261X.
Stulz, N., Lutz, W. G., Leach, C., Lucock, M., & Barkham, M. (2007). Shapes of
early change in psychotherapy under routine outpatient conditions. Journal
of consulting and Clinical Psychology, 75(6), 864–874. doi:10.1037/
0022-006x.75.6.864.
Sunderland, M., Wong, N. R., Hilvert-Bruce, Z., & Andrews, G. (2012).
Investigating trajectories of change in psychological distress amongst
patients with depression and generalised anxiety disorder treated with inter-
net cognitive behavioural therapy. Behaviour Research and Therapy, 50(6),
374–380. doi:10.1016/j.brat.2012.03.005.
Tiemens, B., Kloos, M., Spijker, J., Ingenhoven, T., Kampman, M., &
Hendriks, G. J. (2019). Lower versus higher frequency of sessions in
starting outpatient mental health care and the risk of a chronic course;
a naturalistic cohort study. BMC Psychiatry, 19(1), 228. doi:10.1186/
s12888-019-2214-4.
Titov, N., Dear, B. F., McMillan, D., Anderson, T., Zou, J., & Sunderland, M.
(2011). Psychometric comparison of the PHQ-9 and BDI-II for measuring
response during treatment of depression. Cognitive Behavioral Therapy, 40
(2), 126–136. doi:10.1080/16506073.2010.550059.
Van, H. L., Dekker, J., Peen, J., Van Aalst, G., & Schoevers, R. A. (2008a).
Identifying patients at risk of complete nonresponse in the outpatient treat-
ment of depression. Psychotherapy and Psychosomatics, 77(6), 358–364.
doi:10.1159/000151389.
Van, H. L., Schoevers, R. A., Kool, S., Hendriksen, M., Peen, J., & Dekker, J.
(2008b). Does early response predict outcome in psychotherapy and com-
bined therapy for major depression? Journal of Affective Disorders, 105
(1-3), 261–265. doi:10.1016/j.jad.2007.04.016.
Wang, J. Y., Mann, F., Lloyd-Evans, B., Ma, R. M., & Johnson, S. (2018).
Associations between loneliness and perceived social support and outcomes
of mental health problems: A systematic review. BMC Psychiatry, 18(1), 156.
https://doi.org/10.1186/s12888-018-1736-5.
Wolitzky-Taylor, K. B., Arch, J. J., Rosenfield, D., & Craske, M. G. (2012).
Moderators and non-specific predictors of treatment outcome for anxiety
disorders: A comparison of cognitive behavioral therapy to acceptance
and commitment therapy. Journal of Consulting and Clinical Psychology,
80(5), 786–799. doi:10.1037/a0029418.
10 Jan Stochl et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291720005395
Downloaded from https://www.cambridge.org/core. University of Dundee Library & Learning Centre, on 18 Mar 2021 at 11:48:55, subject to the Cambridge Core terms of use, available at
